AI app aims to ease chemo side effects for breast cancer patients
NCT ID NCT07273812
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests an Arabic-language AI mobile app designed to support women with breast cancer during chemotherapy. The app monitors symptoms, sends medication reminders, and provides educational content. Researchers will compare 130 women who use the app plus usual care to those who receive usual care alone, measuring changes in symptom burden, medication adherence, and quality of life over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-based mobile application (AI Breast Cancer Support App)
What this could lead to
If it works, this app could help women with breast cancer better manage chemotherapy side effects, take their medications on time, and feel more informed about their treatment.
What could go wrong
This is a small, early-stage trial (130 participants) testing a support tool, not a treatment. The app is for education only and may not reduce symptoms or improve outcomes for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Oncology Teaching Hospital-Medical City- Baghdad
RECRUITINGBaghdad, Iraq
Contact Phone: •••-•••-•••• Email: •••••@•••••